• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Russia claims its coronavirus vaccine ‘Sputnik V’ 92% effective

Shiloh

Editor, Senior Moderator
Source: https://globalnews.ca/news/7455995/russia-coronavirus-vaccine-sputnik-v/


Russia claims its coronavirus vaccine ‘Sputnik V’ 92% effective
By Polina Ivanova Reuters
Posted November 11, 2020 11:19 am

Russia says its Sputnik V coronavirus vaccine is 92 per cent effective at protecting people from COVID-19 according to interim trial results, as the global race for a vaccine accelerates to help end the pandemic that has claimed more 1.26 million lives worldwide.

An analysis was conducted after 20 participants developed the novel coronavirus and examined how many had received the vaccine versus a placebo, the Russian Direct Investment Fund (RDIF), which has been backing the vaccine development, said on Wednesday.

The results were based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine...
 
Back
Top Bottom